What is a contraindication for stress testing in clients with CHF?

What is a contraindication for stress testing in clients with CHF?

• A. A normal resting ECG at rest makes stress testing unsafe.
• B. CHF patients with a history of stroke should not undergo stress testing.
• C. CHF patients should not undergo any tests.
• D. Resting ECG anomalies reduce sensitivity of stress testing in CHF.

Answer: (D)

The key idea is that baseline ECG abnormalities at rest make it hard to interpret stress-induced changes, so the test becomes less reliable in detecting ischemia for someone with CHF. When a patient has resting ECG anomalies—such as conduction blocks, prior infarct patterns, or other persistent ST-T changes—those baseline findings can mimic or mask the ECG signs that a stress test looks for when the heart is stressed. As a result, the test’s sensitivity drops, meaning it’s more likely to miss real ischemia or give confusing results. That reduced diagnostic value is why resting ECG anomalies are viewed as a limiting factor for stress testing in CHF. In practice, clinicians might choose alternative or adjunctive imaging methods to assess ischemia or heart function instead of relying solely on a standard stress test. Normal resting ECGs are generally not a safety issue; a history of stroke isn’t an automatic contraindication to stress testing; and CHF patients can undergo tests under appropriate indications. The important point here is that resting ECG abnormalities lessen the test’s usefulness by lowering its ability to detect ischemia.

The key idea is that baseline ECG abnormalities at rest make it hard to interpret stress-induced changes, so the test becomes less reliable in detecting ischemia for someone with CHF. When a patient has resting ECG anomalies—such as conduction blocks, prior infarct patterns, or other persistent ST-T changes—those baseline findings can mimic or mask the ECG signs that a stress test looks for when the heart is stressed. As a result, the test’s sensitivity drops, meaning it’s more likely to miss real ischemia or give confusing results. That reduced diagnostic value is why resting ECG anomalies are viewed as a limiting factor for stress testing in CHF. In practice, clinicians might choose alternative or adjunctive imaging methods to assess ischemia or heart function instead of relying solely on a standard stress test.

Normal resting ECGs are generally not a safety issue; a history of stroke isn’t an automatic contraindication to stress testing; and CHF patients can undergo tests under appropriate indications. The important point here is that resting ECG abnormalities lessen the test’s usefulness by lowering its ability to detect ischemia.